Tallman MS. Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the PROS. haematol [Internet]. 2025Jul.1 [cited 2025Dec.5];110(7):1454-8. Available from: https://haematologica.org/article/view/12012